Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar

Clinical and Vaccine Immunology

Volumn 17, Issue 7, 2010, Pages 1094-1103

  Rakotosamimanana, Niaina ^a   Raharimanga, Vaomalala ^a   Andriamandimby, Soa Fy ^a   Soares, Jean Louis ^a   Doherty, T Mark ^b   Ratsitorahina, Maherisoa ^a   Ramarokoto, Herimanana ^a,c   Zumla, Alimuddin ^d   Huggett, Jim ^d   Rook, Graham ^d   Richard, Vincent ^a   Gicquel, Brigitte ^e   Rasolofo Razanamparany, Voahangy ^a   Fletcher, Helen ^d   Kim, Louise ^d   Chintu, Chifumbe ^f   Mulundu, Gina ^f   Mwaba, Peter ^f   McAdam, K P W J ^g   Owiafe, Patrick ^g   Warndorff, David ^g   Lienhardt, Christian ^g   Brookes, R ^g   Hill, Phillip ^g   Engers, Howard ^g   Aseffa, Abraham ^g   Demissie, Abebech ^g   Abebe, Markos ^g   Wassie, Liya ^g   more..

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b STATENS SERUM INSTITUT   (Denmark)

^c Ministry of Health   (Madagascar)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e INSTITUT PASTEUR   (France)

^f UNIVERSITY OF ZAMBIA   (Zambia)

^g University of Zambia School of Medicine ^*  (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; MADAGASCAR; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPUTUM; BIOSYNTHESIS; BLOOD; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MONONUCLEAR CELL; SPECIES DIFFERENCE;

ANTIGENS, BACTERIAL; DATA COLLECTION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MADAGASCAR; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY;

EID: 77954352415     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00049-10     Document Type: Article

References (64)

1. Aagaard, C., T. T. Hoang, A. Izzo, R. Billeskov, J. Troudt, K. Arnett, A. Keyser, T. Elvang, P. Andersen, and J. Dietrich. 2009. Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS One 4:e5930.
2. Andersen, P., and T. M. Doherty. 2005. The success and failure of BCG: implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3:656-662.
3. Andersen, P., T. M. Doherty, M. Pai, and K. Weldingh. 2007. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol. Med. 13:175-182. (Pubitemid 46687128)
4. Arend, S. M., P. Andersen, K. E. van Meijgaarden, R. L. Skjot, Y. W. Subronto, J. T. van Dissel, and T. H. Ottenhoff. 2000. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J. Infect. Dis. 181:1850-1854.
5. Arnold, C. 2007. Molecular evolution of Mycobacterium tuberculosis. Clin. Microbiol. Infect. 13:120-128.
6. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-1523. (Pubitemid 129524431)
7. Bifani, P. J., B. Mathema, N. E. Kurepina, and B. N. Kreiswirth. 2002. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 10:45-52.
8. Borgdorff, M. W., H. Van Deutekom, P. E. De Haas, K. Kremer, and D. Van Soolingen. 2004. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb.) 84:337-340.
9. Brosch, R., S. V. Gordon, M. Marmiesse, P. Brodin, C. Buchrieser, K. Eiglmeier, T. Garnier, C. Gutierrez, G. Hewinson, K. Kremer, L. M. Parsons, A. S. Pym, S. Samper, D. van Soolingen, and S. T. Cole. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. U. S. A. 99:3684-3689.
10. Brudey, K., J. R. Driscoll, L. Rigouts, W. M. Prodinger, A. Gori, S. A. Al-Hajoj, C. Allix, L. Aristimuno, J. Arora, V. Baumanis, L. Binder, P. Cafrune, A. Cataldi, S. Cheong, R. Diel, C. Ellermeier, J. T. Evans, M. Fauville-Dufaux, S. Ferdinand, D. Garcia de Viedma, C. Garzelli, L. Gazzola, H. M. Gomes, M. C. Guttierez, P. M. Hawkey, P. D. van Helden, G. V. Kadival, B. N. Kreiswirth, K. Kremer, M. Kubin, S. P. Kulkarni, B. Liens, T. Lillebaek, M. L. Ho, C. Martin, C. Martin, I. Mokrousov, O. Narvskaia, Y. F. Ngeow, L. Naumann, S. Niemann, I. Parwati, Z. Rahim, V. Rasolofo-Razanamparany, T. Rasolonavalona, M. L. Rossetti, S. Rusch-Gerdes, A. Sajduda, S. Samper, I. G. Shemyakin, U. B. Singh, A. Somoskovi, R. A. Skuce, D. van Soolingen, E. M. Streicher, P. N. Suffys, E. Tortoli, T. Tracevska, V. Vincent, T. C. Victor, R. M. Warren, S. F. Yap, K. Zaman, F. Portaels, N. Rastogi, and C. Sola. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 6:23.
11. Canetti, G., N. Rist, and J. Grosset. 1963. Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation. Rev. Tuberc. Pneumol. (Paris) 27:217-272. (In French.)
12. Caws, M., G. Thwaites, S. Dunstan, T. R. Hawn, N. T. Lan, N. T. Thuong, K. Stepniewska, M. N. Huyen, N. D. Bang, T. H. Loc, S. Gagneux, D. van Soolingen, K. Kremer, M. van der Sande, P. Small, P. T. Anh, N. T. Chinh, H. T. Quy, N. T. Duyen, D. Q. Tho, N. T. Hieu, E. Torok, T. T. Hien, N. H. Dung, N. T. Nhu, P. M. Duy, N. van Vinh Chau, and J. Farrar. 2008. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 4:e1000034.
13. Champetier de Ribes, G., G. Ranaivoson, E. Rakotoherisoa, B. Andriamahefazafy, and S. Blanchy. 1997. Annual risk of tuberculosis infection in Madagascar: study from 1991 to 1994. Bull. Soc Pathol. Exot. 90:349-352. (In French.)
14. de Jong, B. C., P. C. Hill, A. Aiken, T. Awine, M. Antonio, I. M. Adetifa, D. J. Jackson-Sillah, A. Fox, K. Deriemer, S. Gagneux, M. W. Borgdorff, K. P. McAdam, T. Corrah, P. M. Small, and R. A. Adegbola. 2008. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J. Infect. Dis. 198:1037-1043.
15. Demissie, A., M. Abebe, A. Aseffa, G. Rook, H. Fletcher, A. Zumla, K. Weldingh, I. Brock, P. Andersen, and T. M. Doherty. 2004. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J. Immunol. 172:6938-6943.
16. Demissie, A., E. M. Leyten, M. Abebe, L. Wassie, A. Aseffa, G. Abate, H. Fletcher, P. Owiafe, P. C. Hill, R. Brookes, G. Rook, A. Zumla, S. M. Arend, M. Klein, T. H. Ottenhoff, P. Andersen, and T. M. Doherty. 2006. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 13:179-186.
17. Dheda, K., R. van Zyl Smit, M. Badri, and M. Pai. 2009. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr. Opin. Pulm. Med. 15: 188-200.
18. Diel, R., R. Loddenkemper, K. Meywald-Walter, S. Niemann, and A. Nienhaus. 2008. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 177:1164-1170.
19. Dietrich, J., C. Aagaard, R. Leah, A. W. Olsen, A. Stryhn, T. M. Doherty, and P. Andersen. 2005. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J. Immunol. 174: 6332-6339.
20. Doherty, T. M., A. Demissie, D. Menzies, P. Andersen, G. Rook, and A. Zumla. 2005. Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. J. Immunol. Methods 298:129-141.
21. Doherty, T. M., A. Demissie, J. Olobo, D. Wolday, S. Britton, T. Eguale, P. Ravn, and P. Andersen. 2002. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol. 40:704-706.
22. Dormans, J., M. Burger, D. Aguilar, R. Hernandez-Pando, K. Kremer, P. Roholl, S. M. Arend, and D. van Soolingen. 2004. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin. Exp. Immunol. 137:460-468.
23. El Helali, N., and P. Vergez. 1993. Identification des mycobactéries. Feuillets Biol. 190:5-18.
24. Ferdinand, S., C. Sola, S. Chanteau, H. Ramarokoto, T. Rasolonavalona, V. Rasolofo-Razanamparany, and N. Rastogi. 2005. A study of spoligotyping-defined Mycobacterium tuberculosis clades in relation to the origin of peopling and the demographic history in Madagascar. Infect. Genet. Evol. 5:340-348.
25. Fletcher, H. A., P. Owiafe, D. Jeffries, P. Hill, G. A. Rook, A. Zumla, T. M. Doherty, and R. H. Brookes. 2004. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology 112:669-673.
26. Gagneux, S., K. DeRiemer, T. Van, M. Kato-Maeda, B. C. de Jong, S. Narayanan, M. Nicol, S. Niemann, K. Kremer, M. C. Gutierrez, M. Hilty, P. C. Hopewell, and P. M. Small. 2006. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 103:2869-2873.
27. Garcia de Viedma, D., G. Lorenzo, P. J. Cardona, N. A. Rodriguez, S. Gordillo, M. J. Serrano, and E. Bouza. 2005. Association between the infectivity of Mycobacterium tuberculosis strains and their efficiency for extrarespiratory infection. J. Infect. Dis. 192:2059-2065.
28. Hanekom, M., G. D. van der Spuy, E. Streicher, S. L. Ndabambi, C. R. McEvoy, M. Kidd, N. Beyers, T. C. Victor, P. D. van Helden, and R. M. Warren. 2007. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J. Clin. Microbiol. 45:1483-1490.
29. Harboe, M., T. Oettinger, H. G. Wiker, I. Rosenkrands, and P. Andersen. 1996. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64:16-22.
30. Higuchi, K., N. Harada, K. Fukazawa, and T. Mori. 2008. Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis (Edinb.) 88:244-248.
31. Higuchi, K., Y. Kawabe, S. Mitarai, T. Yoshiyama, N. Harada, and T. Mori. 2009. Comparison of performance in two diagnostic methods for tuberculosis infection. Med. Microbiol. Immunol. 198:33-37.
32. Hill, P. C., D. Jackson-Sillah, A. Fox, K. L. Franken, M. D. Lugos, D. J. Jeffries, S. A. Donkor, A. S. Hammond, R. A. Adegbola, T. H. Ottenhoff, M. R. Klein, and R. H. Brookes. 2005. ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of Mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in The Gambia. J. Clin. Microbiol. 43:2070-2074.
33. Huet, G., P. Constant, W. Malaga, M. A. Laneelle, K. Kremer, D. van Soolingen, M. Daffe, and C. Guilhot. 2009. A lipid profile typifies the Beijing strains of Mycobacterium tuberculosis: identification of a mutation responsible for a modification of the structures of phthiocerol dimycocerosates and phenolic glycolipids. J. Biol. Chem. 284:27101-27113.
34. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
35. Kong, Y., M. D. Cave, L. Zhang, B. Foxman, C. F. Marrs, J. H. Bates, and Z. H. Yang. 2007. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J. Clin. Microbiol. 45:409-414.
36. Lalvani, A., R. Brookes, S. Hambleton, W. J. Britton, A. V. Hill, and A. J. McMichael. 1997. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186:859-865.
37. Lalvani, A., A. A. Pathan, H. Durkan, K. A. Wilkinson, A. Whelan, J. J. Deeks, W. H. Reece, M. Latif, G. Pasvol, and A. V. Hill. 2001. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357:2017-2021.
38. Lazzarini, L. C., R. C. Huard, N. L. Boechat, H. M. Gomes, M. C. Oelemann, N. Kurepina, E. Shashkina, F. C. Mello, A. L. Gibson, M. J. Virginio, A. G. Marsico, W. R. Butler, B. N. Kreiswirth, P. N. Suffys, E. S. J. R. Lapa, and J. L. Ho. 2007. Discovery of a novel Mycobacterium tuberculosis lineage that is a major cause of tuberculosis in Rio de Janeiro, Brazil. J. Clin. Microbiol. 45:3891-3902.
39. Lopez, B., D. Aguilar, H. Orozco, M. Burger, C. Espitia, V. Ritacco, L. Barrera, K. Kremer, R. Hernandez-Pando, K. Huygen, and D. van Soolingen. 2003. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 133:30-37.
40. Manca, C., M. B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C. E. Barry III, and G. Kaplan. 2004. Differential monocyte activation underlies strainspecific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 72:5511-5514.
41. Maree, F., A. C. Hesseling, H. S. Schaaf, B. J. Marais, N. Beyers, P. van Helden, R. M. Warren, and J. F. Schoeman. 2007. Absence of an association between Mycobacterium tuberculosis genotype and clinical features in children with tuberculous meningitis. Pediatr. Infect. Dis. J. 26:13-18.
42. Millington, K. A., J. A. Innes, S. Hackforth, T. S. Hinks, J. J. Deeks, D. P. Dosanjh, V. Guyot-Revol, R. Gunatheesan, P. Klenerman, and A. Lalvani. 2007. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178:5217-5226.
43. Nicol, M. P., C. Sola, B. February, N. Rastogi, L. Steyn, and R. J. Wilkinson. 2005. Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape Town, South Africa. J. Clin. Microbiol. 43:5779-5781.
44. Ordway, D., M. Henao-Tamayo, M. Harton, G. Palanisamy, J. Troudt, C. Shanley, R. J. Basaraba, and I. M. Orme. 2007. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179:522-531.
45. Ordway, D. J., L. Costa, M. Martins, H. Silveira, L. Amaral, M. J. Arroz, F. A. Ventura, and H. M. Dockrell. 2004. Increased interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J. Infect. Dis. 190:756-766.
46. Rasolofo-Razanamparany, V., H. Ramarokoto, G. Auregan, B. Gicquel, and S. Chanteau. 2001. A combination of two genetic markers is sufficient for restriction fragment length polymorphism typing of Mycobacterium tuberculosis complex in areas with a high incidence of tuberculosis. J. Clin. Microbiol. 39:1530-1535.
47. Rasolofo Razanamparany, V., D. Menard, G. Auregan, B. Gicquel, and S. Chanteau. 2002. Extrapulmonary and pulmonary tuberculosis in Antananarivo (Madagascar): high clustering rate in female patients. J. Clin. Microbiol. 40:3964-3969.
48. Reed, M. B., P. Domenech, C. Manca, H. Su, A. K. Barczak, B. N. Kreiswirth, G. Kaplan, and C. E. Barry III. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431:84-87.
49. Ribeiro, S., K. Dooley, J. Hackman, C. Loredo, A. Efron, R. E. Chaisson, M. B. Conde, N. Boechat, and S. E. Dorman. 2009. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect. Dis. 9:23.
50. Sinsimer, D., G. Huet, C. Manca, L. Tsenova, M. S. Koo, N. Kurepina, B. Kana, B. Mathema, S. A. Marras, B. N. Kreiswirth, C. Guilhot, and G. Kaplan. 2008. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect. Immun. 76:3027-3036.
51. Skjot, R. L., I. Brock, S. M. Arend, M. E. Munk, M. Theisen, T. H. Ottenhoff, and P. Andersen. 2002. Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infect. Immun. 70:5446-5453.
52. Smith, P. G., and A. R. Moss. 1994. Epidemiology of tuberculosis, p. 47-59. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, DC.
53. Sorensen, A. L., S. Nagai, G. Houen, P. Andersen, and A. B. Andersen. 1995. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63:1710-1717.
54. Sun, Y. J., T. K. Lim, A. K. Ong, B. C. Ho, G. T. Seah, and N. I. Paton. 2006. Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infect. Dis. 6:105.
55. Tacquet, A., and F. Tison. 1961. Nouvelle technique d'isolement des mycobactéries par le lauryl sulfate de sodium. Ann. Inst. Pasteur (Paris) 100:676-680.
56. Tanveer, M., Z. Hasan, A. Kanji, R. Hussain, and R. Hasan. 2009. Reduced TNF-alpha and IFN-gamma responses to Central Asian strain 1 and Beijing isolates of Mycobacterium tuberculosis in comparison with H37Rv strain. Trans. R. Soc. Trop. Med. Hyg. 103:581-587.
57. Theus, S. A., M. D. Cave, K. Eisenach, J. Walrath, H. Lee, W. Mackay, C. Whalen, and R. F. Silver. 2006. Differences in the growth of paired Ugandan isolates of Mycobacterium tuberculosis within human mononuclear phagocytes correlate with epidemiological evidence of strain virulence. Infect. Immun. 74:6865-6876.
58. Theus, S. A., M. D. Cave, and K. D. Eisenach. 2005. Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics. J. Infect. Dis. 191:453-460.
59. Thwaites, G., M. Caws, T. T. Chau, A. D'Sa, N. T. Lan, M. N. Huyen, S. Gagneux, P. T. Anh, D. Q. Tho, E. Torok, N. T. Nhu, N. T. Duyen, P. M. Duy, J. Richenberg, C. Simmons, T. T. Hien, and J. Farrar. 2008. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J. Clin. Microbiol. 46:1363-1368.
60. Tsenova, L., E. Ellison, R. Harbacheuski, A. L. Moreira, N. Kurepina, M. B. Reed, B. Mathema, C. E. Barry III, and G. Kaplan. 2005. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J. Infect. Dis. 192:98-106.
61. Ulrichs, T., R. Anding, S. H. Kaufmann, and M. E. Munk. 2000. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int. J. Tuber. Lung Dis. 4:1181-1183.
62. van Crevel, R., R. H. Nelwan, W. de Lenne, Y. Veeraragu, A. G. van der Zanden, Z. Amin, J. W. van der Meer, and D. van Soolingen. 2001. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg. Infect. Dis. 7:880-883.
63. van Soolingen, D., P. W. Hermans, P. E. de Haas, D. R. Soll, and J. D. van Embden. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
64. WHO. 2009. Global tuberculosis control 2009: epidemiology, strategy, financing, vol. WHO/HTM/TB/2009.411. World Health Organization, Geneva, Switzerland.